Egypt, Elsewedy review progress on Ain Sokhna phosphate complex    US employment cost index 3.6% up in year to June 2025    Egypt welcomes Canada, Malta's decision to recognise Palestinian state    Pakistan says successfully concluded 'landmark trade deal' with US    Sterling set for sharpest monthly drop since 2022    Egypt, Brazil sign deal to boost pharmaceutical cooperation    Modon Holding posts AED 2.1bn net profit in H1 2025    Egypt's Electricity Ministry says new power cable for Giza area operational    Egypt's Al-Sisi, Italian defence minister discuss Gaza, security cooperation    Egypt's FM discusses Gaza, Nile dam with US senators    Aid airdrops intensify as famine deepens in Gaza amid mounting international criticism    Egypt exports first high-tech potato seeds to Uzbekistan after opening market    Health minister showcases AI's impact on healthcare at Huawei Cloud Summit    On anti-trafficking day, Egypt's PM calls fight a 'moral and humanitarian duty'    Egypt strengthens healthcare partnerships to enhance maternity, multiple sclerosis, and stroke care    Egypt keeps Gaza aid flowing, total tops 533,000 tons: minister    Indian Embassy to launch cultural festival in Assiut, film fest in Cairo    Egyptian aid convoy heads toward Gaza as humanitarian crisis deepens    Culture minister launches national plan to revive film industry, modernise cinematic assets    I won't trade my identity to please market: Douzi    Sisi sends letter to Nigerian president affirming strategic ties    Two militants killed in foiled plot to revive 'Hasm' operations: Interior ministry    Egypt, Somalia discuss closer environmental cooperation    Egypt's EHA, Huawei discuss enhanced digital health    Foreign, housing ministers discuss Egypt's role in African development push    Egypt reveals heritage e-training portal    Three ancient rock-cut tombs discovered in Aswan    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Pharmaceutical Giant Inaugurates First Plant in Middle East
Published in Daily News Egypt on 14 - 12 - 2006

AstraZeneca CEO believes Egypt has made great strides in industry
A $32-million factory was officially opened Monday in 6th of October city by international pharmaceutical behemoth AstraZeneca, the first plant built by the company in the Middle East.
The plant boasts three production lines over 7000 square meters with an output of 250 million tablets a year, which can later be increased to 400 million. The plant will produce cardiovascular, psychiatric and oncology (cancer) drugs.
In an interview with The Daily Star Egypt, AstraZeneca CEO David Brennan said the climate in Egypt was now conducive for this sort of investment.
"The new Egyptian economic policies have created an excellent climate he said.
Brennan had earlier said in the press conference for the inauguration, with Minister of Health and Population Hatem El-Gabaly in attendance, that Egypt has made great strides in the pharmaceutical industry and AstraZeneca had been greatly encouraged by the Ministry's reforming of the price system and adopting the WTO "TRIPS agreement which protects intellectual property rights.
The Egyptian drug industry is worth LE 8.6 billion a year and is second only to South Africa in the continent. AstraZeneca earned $23 billion in healthcare sales for 2005.
For his part El-Gabaly said in his speech "This is a symbol of our policy in attracting investment and turning it into something tangible. Foreign investment is a partner in the growth of the Egyptian economy just as much as local investment.
Brennan told reporters there is a great opportunity for growth in the Egyptian market and AstraZeneca has positioned itself properly in the last few years to take advantage of this.
He told The Daily Star Egypt "We have a wide variety of products and there is differentiation in the product line. For example our product Atacand treats heart failure and high blood pressure. We have a strong research and development department in (the areas of) cardiovascular and oncology treatments.
Brennan added that the company has made a commitment to prepare its business for emerging markets, Egypt included, to help them develop. "I think what we saw (here) was an opportunity to see what happens. There's more demand in emerging markets and the pharmaceutical industry is placed to (partake) in that. Good macro-economic policies lead to good GDP (for emerging markets), he told the Daily Star Egypt.
AstraZeneca's Executive Vice President of Operations David Smith told The Daily Star Egypt "We have been pretty impressed by the talent and diversity we have seen here in Egypt. They are committed and energetic.they want to get things done.
Many of AstraZeneca's products will be produced by the new plant and available for the Egyptian market, including the heart medicine Nexium and the psychiatric drug Seroquel, which will have a sustained release over the year.


Clic here to read the story from its source.